Health Canada — Medical Devices · Canada · 2025-10-22 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: The Monnal EVA V2 (2nd generation - expiratory valve) used on Monnal T60/T60 Advanced ventilators can lead to under-delivery of volumes in "child/infant" patients due to poor membrane sealing. No patient incidents have been reported; the detection occurred during tests. Air liquide medical systems is recalling these valves to replace them with the first generation to prevent the risk of hypoventilation.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.